Skip to content
healthcare.dev

lamivudine

NDC 68999-706, lamivudine oral, solution, from Chartwell Govermental & Specialty RX, LLC..

Product NDC
68999-706
Status
Listed
Labeler
Chartwell Govermental & Specialty RX, LLC.
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203564
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68999-706 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMIVUDINE10 mg/mL

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
68999-706-24689990706242 TRAY in 1 BOX (68999-706-24) / 10 CUP in 1 TRAY / 30 mL in 1 CUP (68999-706-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b23aea53-324b-4ff2-8736-639e4045e388

Use it

Look up 68999-706 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68999-706 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68999-706. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.